Orchard Therapeutics Plc ADR (ORTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -150,660 | -144,584 | -151,979 | -163,422 | -230,495 |
| Depreciation Amortization | 2,162 | 2,804 | 361 | -2,856 | -5,101 |
| Income taxes - deferred | -3,283 | 1,131 | -2,257 | -2,942 | N/A |
| Accounts receivable | -7,420 | -624 | 582 | 715 | -927 |
| Accounts payable and accrued liabilities | N/A | N/A | -12,278 | -6,413 | 14,848 |
| Other Working Capital | 36,476 | -30,185 | -3,628 | -14,787 | 36,518 |
| Other Operating Activity | 46,738 | 46,361 | 42,925 | 23,574 | 87,621 |
| Operating Cash Flow | $-75,987 | $-125,097 | $-126,274 | $-166,131 | $-97,536 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 89,108 | -29,146 | 168,171 | -304,991 | N/A |
| PPE Investments | -6,514 | -2,348 | -2,668 | -4,367 | -4,032 |
| Purchase Sale Intangibles | N/A | -887 | N/A | N/A | N/A |
| Other Investing Activity | 7,966 | -671 | -8,124 | 0 | 0 |
| Investing Cash Flow | $90,560 | $-32,165 | $157,379 | $-309,358 | $-4,032 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 7,375 | N/A | 24,466 | N/A |
| Common Stock Issued | N/A | 154,135 | N/A | 133,592 | 209,697 |
| Other Financing Activity | -693 | -3,444 | 3,936 | -605 | 145,167 |
| Financing Cash Flow | $-693 | $158,066 | $3,936 | $157,453 | $354,864 |
| Exchange Rate Effect | -1,419 | -27 | 1,043 | 1,672 | -3,471 |
| Beginning Cash Position | 60,178 | 59,401 | 23,317 | 339,681 | 89,856 |
| End Cash Position | 72,639 | 60,178 | 59,401 | 23,317 | 339,681 |
| Net Cash Flow | $12,461 | $777 | $36,084 | $-316,364 | $249,825 |
| Free Cash Flow | |||||
| Operating Cash Flow | -75,987 | -125,097 | -126,274 | -166,131 | -97,536 |
| Capital Expenditure | -6,514 | -2,348 | -2,668 | -4,367 | -4,032 |
| Free Cash Flow | -82,501 | -127,445 | -128,942 | -170,498 | -101,568 |